CanaQuest Medical Corp.(OTCPK: CANQF)-Targeting Same Mental Health Space Where GW Pharma was Acquired for U$7.2B Last Month – Initiating Coverage

Mar 19, 2021 | Cannabis, Industry, Research Reports

CanaQuest Medical Corp.(OTCPK: CANQF)-Targeting Same Mental Health Space Where GW Pharma was Acquired for U$7.2B Last Month – Initiating Coverage

Highlights

Two IP protected products, Mentanine® and Mentabinol®, made through cannabinoid molecules to address mental health issues. The products are ready for commercialization as non-Rx (non-prescription drugs) products in Canada, and the U.S.

- - To read more about CanaQuest Medical Corp. click below on downloads

Visit CanaQuest Medical Corp. page for more research, discussion boards and to like, and share.

Download Analyst Report :

Please log in or subscribe to download and read this report.

Investors are also interested in:

Halo Collective Inc.(NEO: HALO / OTCQX: HCANF / GERMANY: A9KN)- Expecting Revenue to More Than Triple in 2021 – Initiating Coverage

Grown Rogue International Inc.(CSE: GRIN / OTC: GRUSF) Recent Acquisition to Boost Indoor Production

Delta 9 Cannabis Inc.(TSX: DN / OTCQX: VRNDF) – Launching Decontamination and COVID-19 Vaccine Storage Tech

Comment On This or Ask Our Analysts a Question Cancel reply

You must be logged in to post a comment.